High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapy

Costantino Mangioni; Silvia Franceschi; Carlo La Vecchia; Maurizio D’Incalci

doi:10.1016/0090-8258(81)90131-1

Related publications

Article2001

Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer

Christos Papadimitriou, Charalambos Kouroussis, Lia A. Moulopoulos, Georgios Vlahos, Alexandros Rodolakis, Christos Kiamouris, Emmanuel Diakomanolis, Dimitra Gika, Stylianos Michalas, Meletios A Dimopoulos

Article2012

Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents

Aristotle Bamias, Christine Bamia, Flora Zagouri, Efthimios Kostouros, Konstantina Kakoyianni, Alexandros Rodolakis, George Vlahos, Dimitrios Haidopoulos, Nikolaos Thomakos, Aris Antsaklis, Meletios A Dimopoulos

Article2007

Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome.

Eleni Efstathiou, Meletios A Dimopoulos, George Bozas, Efstathios Kastritis, Lia A. Moulopoulos, Alexandros Rodolakis, George Vlahos, Dimitra Gika, Christos Papadimitriou, Aristotelis Bamias

Article1997

Ifosfamide and paclitaxel salvage chemotherapy for advanced epithelial ovarian cancer

Meletios A Dimopoulos, Christos Papadimitriou, C. Gennatas, T. Akrivos, George Vlahos, Zannis Voulgaris, E. Diacomanolis, P. Athanassiades, S. Mihalas

Article1998

Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.

George Fountzilas, A. Athanassiades, Vaios Papadimitriou, Meletios A Dimopoulos, D. Bafaloukos, Gerasimos Aravantinos, C. Nicolaides, Haralabos P. Kalofonos, Pavlos Papakostas, Nikolaos I. Xiros, Esma Razi